Effects of water deprivation for 72 hours on the pharmacokinetics of a new carbapenem, DA-1131, in rats

Life Sciences

Volumn 71, Issue 19, 2002, Pages 2291-2298

  Kim, So Hee ^a   Kwon, Jong Won ^b   Kim, Won Bae ^b   Lee, Inchul ^c   Lee, Myung Gull ^d  

^a Gangneung Wonju National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

DA 1131; Pharmacokinetics; Rats; Water deprivation for 72 hr

Indexed keywords

6 (1 HYDROXYETHYL) 2 [2 (3 METHANESULFONYLAMINO 1 PROPENYL) 4 PYRROLIDINYLTHIO] 1 METHYL 1 CARBAPEN 2 EM 3 CARBOXYLIC ACID; AMINOACYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; ENZYME ACTIVITY; KIDNEY CLEARANCE; KIDNEY FUNCTION; LIVER FUNCTION; MALE; NONHUMAN; RAT; WATER DEPRIVATION;

ANIMALS; CARBAPENEMS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; WATER DEPRIVATION;

EID: 0037183760     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01994-X     Document Type: Article

References (23)

1. Bakar S.K., Niazi S. Effect of water deprivation on aspirin disposition kinetics. Journal of Pharmaceutical Sciences. 72(9):1983;1030-1034.
2. Ha H.A., Lee S.H., Kim S.H., Kim O.N., Lee M.G. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats. Research Communications in Molecular Pathology and Pharmacology. 93(1):1996;109-128.
3. Son I.J., Moon Y.J., Lee M.G., Sohn Y.T. No effect of water deprivation for 48 hours on the pharmacokinetic of intravenous tacrolimus in rats. Research Communications in Molecular Pathology and Pharmacology. 107(3&4):2000;279-289.
4. Lee H.J., Lee M.G. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours. Research Communications in Molecular Pathology and Pharmacology. 96(3):1997;299-306.
5. Kim G.W., Chang M.S., Lee K.W., Chong Y.S., Yang J. Comparative in vitro antibacterial activity of DA-1131, a new carbapenem antibiotic (I). Annual Meeting of the Korea Society of Applied Pharmacology. 1996, April 18-19;237 Seoul National University, Seoul, Korea.
6. Kim S.H., Kwon J.W., Kim W.B., Lee M.G. Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs. Antimicrobial Agents and Chemotherapy. 43(10):1999;2524-2527.
7. Kim S.H., Kim W.B., Lee M.G. Pharmacokinetic changes of a new carbapenem, DA-1131, after intravenous administration to spontaneously hypertensive rats and deoxycorticosterone acetate-salt-induced hypertensive rats. Drug Metabolism and Disposition. 27(6):1999;710-716.
8. Kropp H., Sundelof J.G., Hajdu R., Kahan F.M. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase. Antimicrobial Agents and Chemotherapy. 22(1):1982;62-70.
9. Mouton J.W., van den Anker J.N. Meropenem clinical pharmacokinetics. Clinical Pharmacokinetics. 28(4):1995;275-286.
10. Kim J.Y., Kim G.W., Choi S.H., We J.S., Park H.S., Yang J. Renal dehydropeptidase-I (DHP-I) stability and pharmacokinetics of DA-1131, a new carbapenem antibiotic. Annual Meeting of the Korea Society of Applied Pharmacology. 1996, April 18-19;238 Seoul National University, Seoul, Korea.
11. Kim S.H., Kim W.B., Lee M.G. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem. Research Communications in Molecular Pathology and Pharmacology. 90(3):1995;347-362.
12. Kim S.H., Kwon J.W., Yang J., Lee M.G. Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 688(1):1997;95-99.
13. Mikami H., Ogashiwa M., Saino Y., Inoue M., Mitsuhashi S. Comparative stability of newly introduced β-lactam antibiotics to renal dipeptidase. Antimicrobial Agents and Chemotherapy. 22(4):1982;693-695.
14. Campbell B.J., Lin Y.-C., Bird M.E. Renal aminopeptidase- and copper-activated peptide hydrolysis. Journal of Biological Chemistry. 238:1963;3632-3639.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
16. Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed. 1982;Dekker, New York.
17. Chiou W.L. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of Pharmacokinetics and Biopharmaceutics. 6(6):1978;539-546.
18. Kim S.H., Choi Y.M., Lee M.G. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. Journal of Pharmacokinetics and Biopharmaceutics. 21(1):1993;1-17.
19. Chiou W.L. New calculation method for mean apparent drug volume of distribution and application to rationale dosage regimens. Journal of Pharmaceutical Sciences. 68(8):1979;1067-1069.
20. Eatman F.B., Colburn W.A., Boxenbaum H.G., Posmanter H.N., Weinfeld R.E., Ronfeld R., Weissman L., Moore J.D., Gibaldi M., Kaplan S.A. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. Journal of Pharmacokinetics and Biopharmaceutics. 5(5):1977;481-494.
21. Chiou W.L. New calculation method of mean total body clearance of drugs and its application to dosage regimens. Journal of Pharmaceutical Sciences. 69(1):1980;90-91.
22. Kim S.G., Kim E.J., Kim Y.G., Lee M.G. Expression of cytochrome P-450s and glutathione S-transferases in the rat liver during water deprivation: Effects of glucose supplementation. Journal of Applied Toxicology. 21(2):2001;123-129.
23. Kim S.H., Kwon J.W., Lee M.G. Pharmacokinetics and tissue distribution of a new carbapenem, DA-1131, after intravenous administration to mice, rats, rabbits and dogs. Biopharmaceutics & Drug Disposition. 19(4):1998;219-229.